Dec 15, 2025
Radiopharm Theranostics (RADX) Stock Explode 200% After Brain Cancer Trial Breakthrough
RADX stock: Radiopharm Theranostics shares jump 200% on positive Phase 2b brain metastases trial data showing 92% concordance with MRI imaging.
The post Radiopharm Theranostics (RADX) Stock Explode 200% After Brain Cancer Trial Breakthrough appeared first on Blockonomi.
Source: Blockonomi →Related News
- 6 hours ago
Uniswap Price Compression Signals Potential Breakout Toward $5.30
- 6 hours ago
Tron Revenue Tops Blockchain Networks with $24.96M Monthly Earnings
- 7 hours ago
HYPE Token Shows Net Daily Emission as HyperCore Buybacks Fall Short of Rewards
- 7 hours ago
Is Bittensor (TAO) the Next Big Crypto Move? Investors Point to Revenue, Scarcit...
- 8 hours ago
Injective Flips Bearish Structure After Monthly Order Block Holds: What’s Next f...